<DOC>
	<DOCNO>NCT02007889</DOCNO>
	<brief_summary>Risk factor parenchymal damage urinary tract infection vesicoureteral reflux ( VUR ) , obstructive uropathy , number flare acute pyelonephritis ( APN ) delay treatment acute infection.The pathogenesis APN relate bacterial virulenece , immune response , tissue factor , apoptosis production free radical lead fibrosis renal scarring . Oxidative stress renal cell may critical factor pathogenesis pyelonephritis whereas pharmacological management oxidative stress response may provide therapeutic effect prevent renal pathology . Animal model show L-carnitine alleviate oxidative stress , acute renal inflammatory injury prevent much effectively carnitine addition conventional antibiotic treatment pyelonephritis.This study simple randomize clinical trial ( RCT ) evaluate effect L-carnitine addition antibiotic prevent renal scar acute pyelonephritis child . Simple non- blind randomize clinical trial 78 patient 2 group ( intervention &amp; control ) conducted.Children age 1 month 10 year positive urine culture , clinical finding , 99mTc-dimercaptosuccinic acid ( DMSA ) scintigraphy-based evidence favor acute pyelonephritis enrol clinical trial . Patients exclude neurogenic bladder , systemic hypertension , obstructive uropathy . Patients Intervention group administer 50 mg/kg/day carnitine divide 2-3 times/day ( maximum 3 g/day ) addition antibiotic regimen patient control group receive antibiotic regimen . Primary outcome development renal scar DMSA renal scan 7th day admission six month intervention compare group secondary outcome incidence severity pyelonephritis response treatment .</brief_summary>
	<brief_title>L-carnitine Prevention Renal Scarring Acute Pyelonephritis</brief_title>
	<detailed_description />
	<mesh_term>Pyelonephritis</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<criteria>Children age 1 month 10 year positive urine culture , clinical finding , 99mTcdimercaptosuccinic acid ( DMSA ) scintigraphybased evidence favor acute pyelonephritis neurogenic bladder , systemic hypertension , obstructive uropathy</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>